Compile Data Set for Download or QSAR

Found 44 hits with Last Name = 'thome' and Initial = 'd'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Cannabinoid receptor 2 (Homo sapiens (Human))	BDBM50257851 ((S)-4-((2',3'-dichlorobiphenyl-4-yl)methyl)-2-phen...) Show SMILES Clc1cccc(c1Cl)-c1ccc(CN2CCO[C@H](C2)c2ccccc2)cc1 |r| Show InChI InChI=1S/C23H21Cl2NO/c24-21-8-4-7-20(23(21)25)18-11-9-17(10-12-18)15-26-13-14-27-22(16-26)19-5-2-1-3-6-19/h1-12,22H,13-16H2/t22-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	104	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Displacement of [3H]Win55212 form human CB2 receptor transfected in HEK cells				Bioorg Med Chem Lett 19: 1604-9 (2009) Article DOI: 10.1016/j.bmcl.2009.02.033 BindingDB Entry DOI: 10.7270/Q2K937DD
					More data for this Ligand-Target Pair
Cannabinoid receptor 2 (Homo sapiens (Human))	BDBM50257851 ((S)-4-((2',3'-dichlorobiphenyl-4-yl)methyl)-2-phen...) Show SMILES Clc1cccc(c1Cl)-c1ccc(CN2CCO[C@H](C2)c2ccccc2)cc1 |r| Show InChI InChI=1S/C23H21Cl2NO/c24-21-8-4-7-20(23(21)25)18-11-9-17(10-12-18)15-26-13-14-27-22(16-26)19-5-2-1-3-6-19/h1-12,22H,13-16H2/t22-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	312	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Displacement of [3H]CP55940 form human CB2 receptor transfected in HEK cells				Bioorg Med Chem Lett 19: 1604-9 (2009) Article DOI: 10.1016/j.bmcl.2009.02.033 BindingDB Entry DOI: 10.7270/Q2K937DD
					More data for this Ligand-Target Pair
Cannabinoid receptor 2 (Homo sapiens (Human))	BDBM50258007 ((S)-N-(2,4-dichlorophenyl)-5-((2-phenylmorpholino)...) Show SMILES Clc1ccc(Nc2ccc(CN3CCO[C@H](C3)c3ccccc3)cn2)c(Cl)c1 |r| Show InChI InChI=1S/C22H21Cl2N3O/c23-18-7-8-20(19(24)12-18)26-22-9-6-16(13-25-22)14-27-10-11-28-21(15-27)17-4-2-1-3-5-17/h1-9,12-13,21H,10-11,14-15H2,(H,25,26)/t21-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	2.65E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Displacement of [3H]Win55212 form human CB2 receptor transfected in HEK cells				Bioorg Med Chem Lett 19: 1604-9 (2009) Article DOI: 10.1016/j.bmcl.2009.02.033 BindingDB Entry DOI: 10.7270/Q2K937DD
					More data for this Ligand-Target Pair
Cannabinoid receptor 2 (Homo sapiens (Human))	BDBM50211843 (2-(2,4-dichlorophenylamino)-4-trifluoromethyl-pyri...) Show SMILES FC(F)(F)c1nc(Nc2ccc(Cl)cc2Cl)ncc1C(=O)NCC1CCOCC1 Show InChI InChI=1S/C18H17Cl2F3N4O2/c19-11-1-2-14(13(20)7-11)26-17-25-9-12(15(27-17)18(21,22)23)16(28)24-8-10-3-5-29-6-4-10/h1-2,7,9-10H,3-6,8H2,(H,24,28)(H,25,26,27)	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	Purchase CHEMBL MCE PC cid PC sid UniChem Patents Similars	Article PubMed	>5.00E+3	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Displacement of [3H]CP55940 form human CB2 receptor transfected in HEK cells				Bioorg Med Chem Lett 19: 1604-9 (2009) Article DOI: 10.1016/j.bmcl.2009.02.033 BindingDB Entry DOI: 10.7270/Q2K937DD
					More data for this Ligand-Target Pair
Cannabinoid receptor 2 (Homo sapiens (Human))	BDBM50258007 ((S)-N-(2,4-dichlorophenyl)-5-((2-phenylmorpholino)...) Show SMILES Clc1ccc(Nc2ccc(CN3CCO[C@H](C3)c3ccccc3)cn2)c(Cl)c1 |r| Show InChI InChI=1S/C22H21Cl2N3O/c23-18-7-8-20(19(24)12-18)26-22-9-6-16(13-25-22)14-27-10-11-28-21(15-27)17-4-2-1-3-5-17/h1-9,12-13,21H,10-11,14-15H2,(H,25,26)/t21-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Displacement of [3H]CP55940 form human CB2 receptor transfected in HEK cells				Bioorg Med Chem Lett 19: 1604-9 (2009) Article DOI: 10.1016/j.bmcl.2009.02.033 BindingDB Entry DOI: 10.7270/Q2K937DD
					More data for this Ligand-Target Pair
Cannabinoid receptor 2 (Homo sapiens (Human))	BDBM50211843 (2-(2,4-dichlorophenylamino)-4-trifluoromethyl-pyri...) Show SMILES FC(F)(F)c1nc(Nc2ccc(Cl)cc2Cl)ncc1C(=O)NCC1CCOCC1 Show InChI InChI=1S/C18H17Cl2F3N4O2/c19-11-1-2-14(13(20)7-11)26-17-25-9-12(15(27-17)18(21,22)23)16(28)24-8-10-3-5-29-6-4-10/h1-2,7,9-10H,3-6,8H2,(H,24,28)(H,25,26,27)	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	Purchase CHEMBL MCE PC cid PC sid UniChem Patents Similars	Article PubMed	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Displacement of [3H]Win55212 form human CB2 receptor transfected in HEK cells				Bioorg Med Chem Lett 19: 1604-9 (2009) Article DOI: 10.1016/j.bmcl.2009.02.033 BindingDB Entry DOI: 10.7270/Q2K937DD
					More data for this Ligand-Target Pair
Prostaglandin G/H synthase 2 (Homo sapiens (Human))	BDBM50070289 (2-Benzyl-6-chloro-3-hydroxy-4-(propane-2-sulfonyl)...) Show SMILES CC(C)S(=O)(=O)c1c(O)n(Cc2ccccc2)c(=O)c2ccc(Cl)cc12 Show InChI InChI=1S/C19H18ClNO4S/c1-12(2)26(24,25)17-16-10-14(20)8-9-15(16)18(22)21(19(17)23)11-13-6-4-3-5-7-13/h3-10,12,23H,11H2,1-2H3	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	60	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Concentration that caused a 50% decrease in the maximal inhibition of Prostaglandin G/H synthase 2 activity as measured by PGE-2 production.				Bioorg Med Chem Lett 8: 1181-6 (1999) BindingDB Entry DOI: 10.7270/Q2TQ60PJ
					More data for this Ligand-Target Pair
Prostaglandin G/H synthase 2 (Homo sapiens (Human))	BDBM50070287 (2-(4-Fluoro-benzyl)-3-hydroxy-4-(propane-2-sulfony...) Show SMILES CC(C)S(=O)(=O)c1c(O)n(Cc2ccc(F)cc2)c(=O)c2ccccc12 Show InChI InChI=1S/C19H18FNO4S/c1-12(2)26(24,25)17-15-5-3-4-6-16(15)18(22)21(19(17)23)11-13-7-9-14(20)10-8-13/h3-10,12,23H,11H2,1-2H3	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	90	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Concentration that caused a 50% decrease in the maximal inhibition of Prostaglandin G/H synthase 2 activity as measured by PGE-2 production; Imax=84%				Bioorg Med Chem Lett 8: 1181-6 (1999) BindingDB Entry DOI: 10.7270/Q2TQ60PJ
					More data for this Ligand-Target Pair
Prostaglandin G/H synthase 2 (Homo sapiens (Human))	BDBM50070291 (6-Chloro-2-(3,4-difluoro-benzyl)-3-hydroxy-4-(prop...) Show SMILES CC(C)S(=O)(=O)c1c(O)n(Cc2ccc(F)c(F)c2)c(=O)c2ccc(Cl)cc12 Show InChI InChI=1S/C19H16ClF2NO4S/c1-10(2)28(26,27)17-14-8-12(20)4-5-13(14)18(24)23(19(17)25)9-11-3-6-15(21)16(22)7-11/h3-8,10,25H,9H2,1-2H3	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	100	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Concentration that caused a 50% decrease in the maximal inhibition of Prostaglandin G/H synthase 2 activity as measured by PGE-2 production.				Bioorg Med Chem Lett 8: 1181-6 (1999) BindingDB Entry DOI: 10.7270/Q2TQ60PJ
					More data for this Ligand-Target Pair
Prostaglandin G/H synthase 2 (Homo sapiens (Human))	BDBM50070286 (4-Benzenesulfonyl-2-benzyl-3-hydroxy-2H-isoquinoli...) Show SMILES Oc1c(c2ccccc2c(=O)n1Cc1ccccc1)S(=O)(=O)c1ccccc1 Show InChI InChI=1S/C22H17NO4S/c24-21-19-14-8-7-13-18(19)20(28(26,27)17-11-5-2-6-12-17)22(25)23(21)15-16-9-3-1-4-10-16/h1-14,25H,15H2	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	140	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Concentration that caused a 50% decrease in the maximal inhibition of Prostaglandin G/H synthase 2 activity as measured by PGE-2 production.				Bioorg Med Chem Lett 8: 1181-6 (1999) BindingDB Entry DOI: 10.7270/Q2TQ60PJ
					More data for this Ligand-Target Pair
Prostaglandin G/H synthase 2 (Homo sapiens (Human))	BDBM50056998 (4-Hydroxy-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[e...) Show SMILES CN1C(C(=O)Nc2ncc(C)s2)=C(O)c2ccccc2S1(=O)=O |t:12| Show InChI InChI=1S/C14H13N3O4S2/c1-8-7-15-14(22-8)16-13(19)11-12(18)9-5-3-4-6-10(9)23(20,21)17(11)2/h3-7,18H,1-2H3,(H,15,16,19)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	Purchase CHEMBL DrugBank MCE KEGG MMDB PC cid PC sid PDB UniChem Similars	DrugBank PDB PubMed	n/a	n/a	160	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Concentration that caused a 50% decrease in the maximal inhibition of Prostaglandin G/H synthase 2 activity as measured by PGE-2 production.				Bioorg Med Chem Lett 8: 1181-6 (1999) BindingDB Entry DOI: 10.7270/Q2TQ60PJ
					More data for this Ligand-Target Pair				3D Structure (crystal)
Prostaglandin G/H synthase 2 (Homo sapiens (Human))	BDBM50070288 (2-(3,4-Difluoro-benzyl)-3-hydroxy-4-(propane-2-sul...) Show SMILES CC(C)S(=O)(=O)c1c(O)n(Cc2ccc(F)c(F)c2)c(=O)c2ccccc12 Show InChI InChI=1S/C19H17F2NO4S/c1-11(2)27(25,26)17-13-5-3-4-6-14(13)18(23)22(19(17)24)10-12-7-8-15(20)16(21)9-12/h3-9,11,24H,10H2,1-2H3	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	200	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Concentration that caused a 50% decrease in the maximal inhibition of Prostaglandin G/H synthase 2 activity as measured by PGE-2 production; Imax=84%				Bioorg Med Chem Lett 8: 1181-6 (1999) BindingDB Entry DOI: 10.7270/Q2TQ60PJ
					More data for this Ligand-Target Pair
Prostaglandin G/H synthase 1 (Homo sapiens (Human))	BDBM50070287 (2-(4-Fluoro-benzyl)-3-hydroxy-4-(propane-2-sulfony...) Show SMILES CC(C)S(=O)(=O)c1c(O)n(Cc2ccc(F)cc2)c(=O)c2ccccc12 Show InChI InChI=1S/C19H18FNO4S/c1-12(2)26(24,25)17-15-5-3-4-6-16(15)18(22)21(19(17)23)11-13-7-9-14(20)10-8-13/h3-10,12,23H,11H2,1-2H3	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	250	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Concentration that caused a 50% decrease in the maximal inhibition of Prostaglandin G/H synthase 1 activity as measured by PGE-2 production.				Bioorg Med Chem Lett 8: 1181-6 (1999) BindingDB Entry DOI: 10.7270/Q2TQ60PJ
					More data for this Ligand-Target Pair
Prostaglandin G/H synthase 2 (Homo sapiens (Human))	BDBM50070290 (2-Benzyl-3-hydroxy-4-(propane-2-sulfonyl)-2H-isoqu...) Show SMILES CC(C)S(=O)(=O)c1c(O)n(Cc2ccccc2)c(=O)c2ccccc12 Show InChI InChI=1S/C19H19NO4S/c1-13(2)25(23,24)17-15-10-6-7-11-16(15)18(21)20(19(17)22)12-14-8-4-3-5-9-14/h3-11,13,22H,12H2,1-2H3	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	290	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Concentration that caused a 50% decrease in the maximal inhibition of Prostaglandin G/H synthase 2 activity as measured by PGE-2 production.				Bioorg Med Chem Lett 8: 1181-6 (1999) BindingDB Entry DOI: 10.7270/Q2TQ60PJ
					More data for this Ligand-Target Pair
Prostaglandin G/H synthase 1 (Homo sapiens (Human))	BDBM50070290 (2-Benzyl-3-hydroxy-4-(propane-2-sulfonyl)-2H-isoqu...) Show SMILES CC(C)S(=O)(=O)c1c(O)n(Cc2ccccc2)c(=O)c2ccccc12 Show InChI InChI=1S/C19H19NO4S/c1-13(2)25(23,24)17-15-10-6-7-11-16(15)18(21)20(19(17)22)12-14-8-4-3-5-9-14/h3-11,13,22H,12H2,1-2H3	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	340	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Concentration that caused a 50% decrease in the maximal inhibition of Prostaglandin G/H synthase 1 activity as measured by PGE-2 production.				Bioorg Med Chem Lett 8: 1181-6 (1999) BindingDB Entry DOI: 10.7270/Q2TQ60PJ
					More data for this Ligand-Target Pair
Prostaglandin G/H synthase 1 (Homo sapiens (Human))	BDBM50070288 (2-(3,4-Difluoro-benzyl)-3-hydroxy-4-(propane-2-sul...) Show SMILES CC(C)S(=O)(=O)c1c(O)n(Cc2ccc(F)c(F)c2)c(=O)c2ccccc12 Show InChI InChI=1S/C19H17F2NO4S/c1-11(2)27(25,26)17-13-5-3-4-6-14(13)18(23)22(19(17)24)10-12-7-8-15(20)16(21)9-12/h3-9,11,24H,10H2,1-2H3	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	570	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Concentration that caused a 50% decrease in the maximal inhibition of Prostaglandin G/H synthase 1 activity as measured by PGE-2 production.				Bioorg Med Chem Lett 8: 1181-6 (1999) BindingDB Entry DOI: 10.7270/Q2TQ60PJ
					More data for this Ligand-Target Pair
Prostaglandin G/H synthase 1 (Homo sapiens (Human))	BDBM50070286 (4-Benzenesulfonyl-2-benzyl-3-hydroxy-2H-isoquinoli...) Show SMILES Oc1c(c2ccccc2c(=O)n1Cc1ccccc1)S(=O)(=O)c1ccccc1 Show InChI InChI=1S/C22H17NO4S/c24-21-19-14-8-7-13-18(19)20(28(26,27)17-11-5-2-6-12-17)22(25)23(21)15-16-9-3-1-4-10-16/h1-14,25H,15H2	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	730	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Concentration that caused a 50% decrease in the maximal inhibition of Prostaglandin G/H synthase 1 activity as measured by PGE-2 production.				Bioorg Med Chem Lett 8: 1181-6 (1999) BindingDB Entry DOI: 10.7270/Q2TQ60PJ
					More data for this Ligand-Target Pair
Prostaglandin G/H synthase 1 (Homo sapiens (Human))	BDBM50070291 (6-Chloro-2-(3,4-difluoro-benzyl)-3-hydroxy-4-(prop...) Show SMILES CC(C)S(=O)(=O)c1c(O)n(Cc2ccc(F)c(F)c2)c(=O)c2ccc(Cl)cc12 Show InChI InChI=1S/C19H16ClF2NO4S/c1-10(2)28(26,27)17-14-8-12(20)4-5-13(14)18(24)23(19(17)25)9-11-3-6-15(21)16(22)7-11/h3-8,10,25H,9H2,1-2H3	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	1.36E+3	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Concentration that caused a 50% decrease in the maximal inhibition of Prostaglandin G/H synthase 1 activity as measured by PGE-2 production.				Bioorg Med Chem Lett 8: 1181-6 (1999) BindingDB Entry DOI: 10.7270/Q2TQ60PJ
					More data for this Ligand-Target Pair
Prostaglandin G/H synthase 1 (Homo sapiens (Human))	BDBM50070289 (2-Benzyl-6-chloro-3-hydroxy-4-(propane-2-sulfonyl)...) Show SMILES CC(C)S(=O)(=O)c1c(O)n(Cc2ccccc2)c(=O)c2ccc(Cl)cc12 Show InChI InChI=1S/C19H18ClNO4S/c1-12(2)26(24,25)17-16-10-14(20)8-9-15(16)18(22)21(19(17)23)11-13-6-4-3-5-7-13/h3-10,12,23H,11H2,1-2H3	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	1.42E+3	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Concentration that caused a 50% decrease in the maximal inhibition of Prostaglandin G/H synthase 1 activity as measured by PGE-2 production.				Bioorg Med Chem Lett 8: 1181-6 (1999) BindingDB Entry DOI: 10.7270/Q2TQ60PJ
					More data for this Ligand-Target Pair
Prostaglandin G/H synthase 1 (Homo sapiens (Human))	BDBM50056998 (4-Hydroxy-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[e...) Show SMILES CN1C(C(=O)Nc2ncc(C)s2)=C(O)c2ccccc2S1(=O)=O |t:12| Show InChI InChI=1S/C14H13N3O4S2/c1-8-7-15-14(22-8)16-13(19)11-12(18)9-5-3-4-6-10(9)23(20,21)17(11)2/h3-7,18H,1-2H3,(H,15,16,19)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	Purchase CHEMBL DrugBank MCE KEGG MMDB PC cid PC sid PDB UniChem Similars	PDB PubMed	n/a	n/a	2.20E+3	n/a	n/a	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Concentration that caused a 50% decrease in the maximal inhibition of Prostaglandin G/H synthase 1 activity as measured by PGE-2 production.				Bioorg Med Chem Lett 8: 1181-6 (1999) BindingDB Entry DOI: 10.7270/Q2TQ60PJ
					More data for this Ligand-Target Pair				3D Structure (crystal)
Cannabinoid receptor 2 (Homo sapiens (Human))	BDBM50257851 ((S)-4-((2',3'-dichlorobiphenyl-4-yl)methyl)-2-phen...) Show SMILES Clc1cccc(c1Cl)-c1ccc(CN2CCO[C@H](C2)c2ccccc2)cc1 |r| Show InChI InChI=1S/C23H21Cl2NO/c24-21-8-4-7-20(23(21)25)18-11-9-17(10-12-18)15-26-13-14-27-22(16-26)19-5-2-1-3-6-19/h1-12,22H,13-16H2/t22-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	n/a	n/a	6	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP release				Bioorg Med Chem Lett 19: 1604-9 (2009) Article DOI: 10.1016/j.bmcl.2009.02.033 BindingDB Entry DOI: 10.7270/Q2K937DD
					More data for this Ligand-Target Pair
Cannabinoid receptor 2 (Homo sapiens (Human))	BDBM50257852 ((S)-4-((2'-chloro-5'-methylbiphenyl-4-yl)methyl)-2...) Show SMILES Cc1ccc(Cl)c(c1)-c1ccc(CN2CCO[C@H](C2)c2ccccc2)cc1 |r| Show InChI InChI=1S/C24H24ClNO/c1-18-7-12-23(25)22(15-18)20-10-8-19(9-11-20)16-26-13-14-27-24(17-26)21-5-3-2-4-6-21/h2-12,15,24H,13-14,16-17H2,1H3/t24-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	n/a	n/a	3	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP release				Bioorg Med Chem Lett 19: 1604-9 (2009) Article DOI: 10.1016/j.bmcl.2009.02.033 BindingDB Entry DOI: 10.7270/Q2K937DD
					More data for this Ligand-Target Pair
Cannabinoid receptor 2 (Homo sapiens (Human))	BDBM50257853 ((S)-4'-((2-phenylmorpholino)methyl)biphenyl-2-carb...) Show SMILES N#Cc1ccccc1-c1ccc(CN2CCO[C@H](C2)c2ccccc2)cc1 |r| Show InChI InChI=1S/C24H22N2O/c25-16-22-8-4-5-9-23(22)20-12-10-19(11-13-20)17-26-14-15-27-24(18-26)21-6-2-1-3-7-21/h1-13,24H,14-15,17-18H2/t24-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	Purchase CHEMBL PC cid PC sid UniChem Patents	Article PubMed	n/a	n/a	n/a	n/a	3	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP release				Bioorg Med Chem Lett 19: 1604-9 (2009) Article DOI: 10.1016/j.bmcl.2009.02.033 BindingDB Entry DOI: 10.7270/Q2K937DD
					More data for this Ligand-Target Pair
Cannabinoid receptor 2 (Homo sapiens (Human))	BDBM50257854 ((S)-N-phenyl-4-((2-phenylmorpholino)methyl)aniline...) Show SMILES C(N1CCO[C@H](C1)c1ccccc1)c1ccc(Nc2ccccc2)cc1 |r| Show InChI InChI=1S/C23H24N2O/c1-3-7-20(8-4-1)23-18-25(15-16-26-23)17-19-11-13-22(14-12-19)24-21-9-5-2-6-10-21/h1-14,23-24H,15-18H2/t23-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	n/a	n/a	n/a	n/a	615	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP release				Bioorg Med Chem Lett 19: 1604-9 (2009) Article DOI: 10.1016/j.bmcl.2009.02.033 BindingDB Entry DOI: 10.7270/Q2K937DD
					More data for this Ligand-Target Pair
Cannabinoid receptor 2 (Homo sapiens (Human))	BDBM50257910 ((S)-4-(4-phenoxybenzyl)-2-phenylmorpholine | CHEMB...) Show SMILES C(N1CCO[C@H](C1)c1ccccc1)c1ccc(Oc2ccccc2)cc1 |r| Show InChI InChI=1S/C23H23NO2/c1-3-7-20(8-4-1)23-18-24(15-16-25-23)17-19-11-13-22(14-12-19)26-21-9-5-2-6-10-21/h1-14,23H,15-18H2/t23-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents	Article PubMed	n/a	n/a	n/a	n/a	1.50E+4	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP release				Bioorg Med Chem Lett 19: 1604-9 (2009) Article DOI: 10.1016/j.bmcl.2009.02.033 BindingDB Entry DOI: 10.7270/Q2K937DD
					More data for this Ligand-Target Pair
Cannabinoid receptor 2 (Homo sapiens (Human))	BDBM50257911 ((S)-N-phenyl-5-((2-phenylmorpholino)methyl)pyridin...) Show SMILES C(N1CCO[C@H](C1)c1ccccc1)c1ccc(Nc2ccccc2)nc1 |r| Show InChI InChI=1S/C22H23N3O/c1-3-7-19(8-4-1)21-17-25(13-14-26-21)16-18-11-12-22(23-15-18)24-20-9-5-2-6-10-20/h1-12,15,21H,13-14,16-17H2,(H,23,24)/t21-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	n/a	n/a	140	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP release				Bioorg Med Chem Lett 19: 1604-9 (2009) Article DOI: 10.1016/j.bmcl.2009.02.033 BindingDB Entry DOI: 10.7270/Q2K937DD
					More data for this Ligand-Target Pair
Cannabinoid receptor 2 (Homo sapiens (Human))	BDBM50257912 ((S)-N-(2,3-dichlorophenyl)-5-((2-phenylmorpholino)...) Show SMILES Clc1cccc(Nc2ccc(CN3CCO[C@H](C3)c3ccccc3)cn2)c1Cl |r| Show InChI InChI=1S/C22H21Cl2N3O/c23-18-7-4-8-19(22(18)24)26-21-10-9-16(13-25-21)14-27-11-12-28-20(15-27)17-5-2-1-3-6-17/h1-10,13,20H,11-12,14-15H2,(H,25,26)/t20-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	n/a	n/a	1.60E+3	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP release				Bioorg Med Chem Lett 19: 1604-9 (2009) Article DOI: 10.1016/j.bmcl.2009.02.033 BindingDB Entry DOI: 10.7270/Q2K937DD
					More data for this Ligand-Target Pair
Cannabinoid receptor 2 (Homo sapiens (Human))	BDBM50257913 ((S)-N-(2-chlorophenyl)-5-((2-phenylmorpholino)meth...) Show SMILES Clc1ccccc1Nc1ccc(CN2CCO[C@H](C2)c2ccccc2)cn1 |r| Show InChI InChI=1S/C22H22ClN3O/c23-19-8-4-5-9-20(19)25-22-11-10-17(14-24-22)15-26-12-13-27-21(16-26)18-6-2-1-3-7-18/h1-11,14,21H,12-13,15-16H2,(H,24,25)/t21-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	n/a	n/a	30	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP release				Bioorg Med Chem Lett 19: 1604-9 (2009) Article DOI: 10.1016/j.bmcl.2009.02.033 BindingDB Entry DOI: 10.7270/Q2K937DD
					More data for this Ligand-Target Pair
Cannabinoid receptor 2 (Homo sapiens (Human))	BDBM50257914 ((S)-N-(3-chlorophenyl)-5-((2-phenylmorpholino)meth...) Show SMILES Clc1cccc(Nc2ccc(CN3CCO[C@H](C3)c3ccccc3)cn2)c1 |r| Show InChI InChI=1S/C22H22ClN3O/c23-19-7-4-8-20(13-19)25-22-10-9-17(14-24-22)15-26-11-12-27-21(16-26)18-5-2-1-3-6-18/h1-10,13-14,21H,11-12,15-16H2,(H,24,25)/t21-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	n/a	n/a	200	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP release				Bioorg Med Chem Lett 19: 1604-9 (2009) Article DOI: 10.1016/j.bmcl.2009.02.033 BindingDB Entry DOI: 10.7270/Q2K937DD
					More data for this Ligand-Target Pair
Cannabinoid receptor 2 (Homo sapiens (Human))	BDBM50257957 ((S)-N-(4-chlorophenyl)-5-((2-phenylmorpholino)meth...) Show SMILES Clc1ccc(Nc2ccc(CN3CCO[C@H](C3)c3ccccc3)cn2)cc1 |r| Show InChI InChI=1S/C22H22ClN3O/c23-19-7-9-20(10-8-19)25-22-11-6-17(14-24-22)15-26-12-13-27-21(16-26)18-4-2-1-3-5-18/h1-11,14,21H,12-13,15-16H2,(H,24,25)/t21-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	n/a	n/a	30	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP release				Bioorg Med Chem Lett 19: 1604-9 (2009) Article DOI: 10.1016/j.bmcl.2009.02.033 BindingDB Entry DOI: 10.7270/Q2K937DD
					More data for this Ligand-Target Pair
Cannabinoid receptor 2 (Homo sapiens (Human))	BDBM50257958 ((S)-N-(4-fluorophenyl)-5-((2-phenylmorpholino)meth...) Show SMILES Fc1ccc(Nc2ccc(CN3CCO[C@H](C3)c3ccccc3)cn2)cc1 |r| Show InChI InChI=1S/C22H22FN3O/c23-19-7-9-20(10-8-19)25-22-11-6-17(14-24-22)15-26-12-13-27-21(16-26)18-4-2-1-3-5-18/h1-11,14,21H,12-13,15-16H2,(H,24,25)/t21-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	n/a	n/a	35	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP release				Bioorg Med Chem Lett 19: 1604-9 (2009) Article DOI: 10.1016/j.bmcl.2009.02.033 BindingDB Entry DOI: 10.7270/Q2K937DD
					More data for this Ligand-Target Pair
Cannabinoid receptor 2 (Homo sapiens (Human))	BDBM50257959 ((S)-5-((2-phenylmorpholino)methyl)-N-p-tolylpyridi...) Show SMILES Cc1ccc(Nc2ccc(CN3CCO[C@H](C3)c3ccccc3)cn2)cc1 |r| Show InChI InChI=1S/C23H25N3O/c1-18-7-10-21(11-8-18)25-23-12-9-19(15-24-23)16-26-13-14-27-22(17-26)20-5-3-2-4-6-20/h2-12,15,22H,13-14,16-17H2,1H3,(H,24,25)/t22-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	n/a	n/a	100	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP release				Bioorg Med Chem Lett 19: 1604-9 (2009) Article DOI: 10.1016/j.bmcl.2009.02.033 BindingDB Entry DOI: 10.7270/Q2K937DD
					More data for this Ligand-Target Pair
Cannabinoid receptor 2 (Homo sapiens (Human))	BDBM50257960 ((S)-N-(4-isopropylphenyl)-5-((2-phenylmorpholino)m...) Show SMILES CC(C)c1ccc(Nc2ccc(CN3CCO[C@H](C3)c3ccccc3)cn2)cc1 |r| Show InChI InChI=1S/C25H29N3O/c1-19(2)21-9-11-23(12-10-21)27-25-13-8-20(16-26-25)17-28-14-15-29-24(18-28)22-6-4-3-5-7-22/h3-13,16,19,24H,14-15,17-18H2,1-2H3,(H,26,27)/t24-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+4	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP release				Bioorg Med Chem Lett 19: 1604-9 (2009) Article DOI: 10.1016/j.bmcl.2009.02.033 BindingDB Entry DOI: 10.7270/Q2K937DD
					More data for this Ligand-Target Pair
Cannabinoid receptor 2 (Homo sapiens (Human))	BDBM50257961 ((S)-N-(4-methoxyphenyl)-5-((2-phenylmorpholino)met...) Show SMILES COc1ccc(Nc2ccc(CN3CCO[C@H](C3)c3ccccc3)cn2)cc1 |r| Show InChI InChI=1S/C23H25N3O2/c1-27-21-10-8-20(9-11-21)25-23-12-7-18(15-24-23)16-26-13-14-28-22(17-26)19-5-3-2-4-6-19/h2-12,15,22H,13-14,16-17H2,1H3,(H,24,25)/t22-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	n/a	n/a	65	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP release				Bioorg Med Chem Lett 19: 1604-9 (2009) Article DOI: 10.1016/j.bmcl.2009.02.033 BindingDB Entry DOI: 10.7270/Q2K937DD
					More data for this Ligand-Target Pair
Cannabinoid receptor 2 (Homo sapiens (Human))	BDBM50258004 ((S)-N1,N1-dimethyl-N4-(5-((2-phenylmorpholino)meth...) Show SMILES CN(C)c1ccc(Nc2ccc(CN3CCO[C@H](C3)c3ccccc3)cn2)cc1 |r| Show InChI InChI=1S/C24H28N4O/c1-27(2)22-11-9-21(10-12-22)26-24-13-8-19(16-25-24)17-28-14-15-29-23(18-28)20-6-4-3-5-7-20/h3-13,16,23H,14-15,17-18H2,1-2H3,(H,25,26)/t23-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+4	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP release				Bioorg Med Chem Lett 19: 1604-9 (2009) Article DOI: 10.1016/j.bmcl.2009.02.033 BindingDB Entry DOI: 10.7270/Q2K937DD
					More data for this Ligand-Target Pair
Cannabinoid receptor 2 (Homo sapiens (Human))	BDBM50258005 ((S)-N-(biphenyl-4-yl)-5-((2-phenylmorpholino)methy...) Show SMILES C(N1CCO[C@H](C1)c1ccccc1)c1ccc(Nc2ccc(cc2)-c2ccccc2)nc1 |r| Show InChI InChI=1S/C28H27N3O/c1-3-7-23(8-4-1)24-12-14-26(15-13-24)30-28-16-11-22(19-29-28)20-31-17-18-32-27(21-31)25-9-5-2-6-10-25/h1-16,19,27H,17-18,20-21H2,(H,29,30)/t27-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+4	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP release				Bioorg Med Chem Lett 19: 1604-9 (2009) Article DOI: 10.1016/j.bmcl.2009.02.033 BindingDB Entry DOI: 10.7270/Q2K937DD
					More data for this Ligand-Target Pair
Cannabinoid receptor 2 (Homo sapiens (Human))	BDBM50258006 ((S)-N-(3,4-dichlorophenyl)-5-((2-phenylmorpholino)...) Show SMILES Clc1ccc(Nc2ccc(CN3CCO[C@H](C3)c3ccccc3)cn2)cc1Cl |r| Show InChI InChI=1S/C22H21Cl2N3O/c23-19-8-7-18(12-20(19)24)26-22-9-6-16(13-25-22)14-27-10-11-28-21(15-27)17-4-2-1-3-5-17/h1-9,12-13,21H,10-11,14-15H2,(H,25,26)/t21-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	n/a	n/a	50	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP release				Bioorg Med Chem Lett 19: 1604-9 (2009) Article DOI: 10.1016/j.bmcl.2009.02.033 BindingDB Entry DOI: 10.7270/Q2K937DD
					More data for this Ligand-Target Pair
Cannabinoid receptor 2 (Homo sapiens (Human))	BDBM50258007 ((S)-N-(2,4-dichlorophenyl)-5-((2-phenylmorpholino)...) Show SMILES Clc1ccc(Nc2ccc(CN3CCO[C@H](C3)c3ccccc3)cn2)c(Cl)c1 |r| Show InChI InChI=1S/C22H21Cl2N3O/c23-18-7-8-20(19(24)12-18)26-22-9-6-16(13-25-22)14-27-10-11-28-21(15-27)17-4-2-1-3-5-17/h1-9,12-13,21H,10-11,14-15H2,(H,25,26)/t21-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	n/a	n/a	10	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP release				Bioorg Med Chem Lett 19: 1604-9 (2009) Article DOI: 10.1016/j.bmcl.2009.02.033 BindingDB Entry DOI: 10.7270/Q2K937DD
					More data for this Ligand-Target Pair
Cannabinoid receptor 2 (Homo sapiens (Human))	BDBM50257800 (CHEMBL494589 | rac-2-phenyl-4-((2'-(trifluoromethy...) Show SMILES FC(F)(F)c1ccccc1-c1ccc(CN2CCOC(C2)c2ccccc2)cc1 Show InChI InChI=1S/C24H22F3NO/c25-24(26,27)22-9-5-4-8-21(22)19-12-10-18(11-13-19)16-28-14-15-29-23(17-28)20-6-2-1-3-7-20/h1-13,23H,14-17H2	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	n/a	n/a	330	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP release				Bioorg Med Chem Lett 19: 1604-9 (2009) Article DOI: 10.1016/j.bmcl.2009.02.033 BindingDB Entry DOI: 10.7270/Q2K937DD
					More data for this Ligand-Target Pair
Cannabinoid receptor 2 (Homo sapiens (Human))	BDBM50257799 (CHEMBL494408 | rac-2-(methyl((2'-(trifluoromethyl)...) Show SMILES CN(CC(O)c1ccccc1)Cc1ccc(cc1)-c1ccccc1C(F)(F)F Show InChI InChI=1S/C23H22F3NO/c1-27(16-22(28)19-7-3-2-4-8-19)15-17-11-13-18(14-12-17)20-9-5-6-10-21(20)23(24,25)26/h2-14,22,28H,15-16H2,1H3	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	n/a	n/a	2	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP release				Bioorg Med Chem Lett 19: 1604-9 (2009) Article DOI: 10.1016/j.bmcl.2009.02.033 BindingDB Entry DOI: 10.7270/Q2K937DD
					More data for this Ligand-Target Pair
Cannabinoid receptor 2 (Homo sapiens (Human))	BDBM50211843 (2-(2,4-dichlorophenylamino)-4-trifluoromethyl-pyri...) Show SMILES FC(F)(F)c1nc(Nc2ccc(Cl)cc2Cl)ncc1C(=O)NCC1CCOCC1 Show InChI InChI=1S/C18H17Cl2F3N4O2/c19-11-1-2-14(13(20)7-11)26-17-25-9-12(15(27-17)18(21,22)23)16(28)24-8-10-3-5-29-6-4-10/h1-2,7,9-10H,3-6,8H2,(H,24,28)(H,25,26,27)	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	Purchase CHEMBL MCE PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	n/a	n/a	350	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP release				Bioorg Med Chem Lett 19: 1604-9 (2009) Article DOI: 10.1016/j.bmcl.2009.02.033 BindingDB Entry DOI: 10.7270/Q2K937DD
					More data for this Ligand-Target Pair
Cannabinoid receptor 2 (Homo sapiens (Human))	BDBM50257801 (CHEMBL494590 | rac-3-phenyl-1-((2'-(trifluoromethy...) Show SMILES FC(F)(F)c1ccccc1-c1ccc(CN2CCCC(C2)c2ccccc2)cc1 Show InChI InChI=1S/C25H24F3N/c26-25(27,28)24-11-5-4-10-23(24)21-14-12-19(13-15-21)17-29-16-6-9-22(18-29)20-7-2-1-3-8-20/h1-5,7-8,10-15,22H,6,9,16-18H2	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents	Article PubMed	n/a	n/a	n/a	n/a	30	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP release				Bioorg Med Chem Lett 19: 1604-9 (2009) Article DOI: 10.1016/j.bmcl.2009.02.033 BindingDB Entry DOI: 10.7270/Q2K937DD
					More data for this Ligand-Target Pair
Cannabinoid receptor 2 (Homo sapiens (Human))	BDBM50257802 ((S)-2-phenyl-4-((2'-(trifluoromethyl)biphenyl-4-yl...) Show SMILES FC(F)(F)c1ccccc1-c1ccc(CN2CCO[C@H](C2)c2ccccc2)cc1 |r| Show InChI InChI=1S/C24H22F3NO/c25-24(26,27)22-9-5-4-8-21(22)19-12-10-18(11-13-19)16-28-14-15-29-23(17-28)20-6-2-1-3-7-20/h1-13,23H,14-17H2/t23-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	n/a	n/a	40	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP release				Bioorg Med Chem Lett 19: 1604-9 (2009) Article DOI: 10.1016/j.bmcl.2009.02.033 BindingDB Entry DOI: 10.7270/Q2K937DD
					More data for this Ligand-Target Pair
Cannabinoid receptor 2 (Homo sapiens (Human))	BDBM50257850 ((S)-4-((2'-chlorobiphenyl-4-yl)methyl)-2-phenylmor...) Show SMILES Clc1ccccc1-c1ccc(CN2CCO[C@H](C2)c2ccccc2)cc1 |r| Show InChI InChI=1S/C23H22ClNO/c24-22-9-5-4-8-21(22)19-12-10-18(11-13-19)16-25-14-15-26-23(17-25)20-6-2-1-3-7-20/h1-13,23H,14-17H2/t23-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	n/a	n/a	25	n/a	n/a	n/a	n/a
Boehringer Ingelheim Pharmaceuticals Curated by ChEMBL					Assay Description Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP release				Bioorg Med Chem Lett 19: 1604-9 (2009) Article DOI: 10.1016/j.bmcl.2009.02.033 BindingDB Entry DOI: 10.7270/Q2K937DD
					More data for this Ligand-Target Pair